Viking Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.38 |
Market Cap |
$591.51 M |
Shares Outstanding |
72.05 M |
Public Float |
63.4 M |
Address |
12340 El Camino Real San Diego California 92130 United States |
Employees | - |
Website | http://www.vikingtherapeutics.com |
Updated | 07/08/2019 |
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. Its clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. |